These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 5537522)

  • 21. [Antiglaucoma ophthalmic agents with prolonged action based on macromolecular excipients. 1. In vitro studies].
    Pergande G; Keipert S
    Pharmazie; 1990 Jul; 45(8):582-6. PubMed ID: 2080203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Experience with a centralized eyedrops preparation with reference to the reduction of microorganism content].
    Meyer H
    Pharm Prax; 1968; 6():158-60. PubMed ID: 5709458
    [No Abstract]   [Full Text] [Related]  

  • 23. [On the suitability of septonex for the preservation of eyedrops].
    Hädicke M
    Pharm Prax; 1968; 6():161-2. PubMed ID: 5709459
    [No Abstract]   [Full Text] [Related]  

  • 24. [Contribtuion to the study of the stability of pilocarpine in aqueous medium. 3. Stability of ophthalmic solutions].
    Baeschlin K; Etter JC
    Pharm Acta Helv; 1969 Jun; 44(6):348-55. PubMed ID: 5805009
    [No Abstract]   [Full Text] [Related]  

  • 25. [Medical treatment of wide-angle chronic glaucoma].
    Offret H; Bechetoille A
    Cah Med; 1974 Apr; 15(4):215-9. PubMed ID: 4434249
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of topical ophthalmic 2 percent pilocarpine on visual performance of normal subjects.
    Lindstrom EE; Tredici TJ; Martin BG
    Aerosp Med; 1968 Nov; 39(11):1236-40. PubMed ID: 5687247
    [No Abstract]   [Full Text] [Related]  

  • 27. The additive effect of latanoprost to maximum-tolerated medications with low-dose, high-dose, or no pilocarpine therapy.
    Shin DH; McCracken MS; Bendel RE; Pearlman R; Juzych MS; Hughes BA; Schulz LL; Kim C; Baek NH
    Ophthalmology; 1999 Feb; 106(2):386-90. PubMed ID: 9951495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative efficacy of pilocarpine, timolol and latanoprost in experimental models of glaucoma.
    Gupta SK; Agarwal R; Galpalli ND; Srivastava S; Agrawal SS; Saxena R
    Methods Find Exp Clin Pharmacol; 2007 Dec; 29(10):665-71. PubMed ID: 18200329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Technology of preparing stable eyedrops of fetanol and its combination with pilocarpine hydrochloride].
    Fauziia Saĭed AKh; Kondrat'eva TS
    Farmatsiia; 1979; 28(5):21-4. PubMed ID: 39795
    [No Abstract]   [Full Text] [Related]  

  • 30. Efficacy of a combination solution of epinephrine and pilocarpine.
    Trotta N; O'Connor R
    Eye Ear Nose Throat Mon; 1971 Sep; 50(9):350-2. PubMed ID: 5567845
    [No Abstract]   [Full Text] [Related]  

  • 31. [Danger of treatment of various glaucomas by collyria combining pilocarpine and neosynephrine].
    Renard P
    Bull Soc Ophtalmol Fr; 1968 Mar; 68(3):344-50. PubMed ID: 5746415
    [No Abstract]   [Full Text] [Related]  

  • 32. Topical corticosteroids in suspected late congenital glaucoma.
    Stanworth A
    Trans Ophthalmol Soc U K (1962); 1964; 84():173-82. PubMed ID: 5227417
    [No Abstract]   [Full Text] [Related]  

  • 33. [Studies of the stability and preparation of 2 per cent L-adrenaline solutions for treatment of wide angle glaucoma].
    Trose D; Wagner C; Nebel M
    Pharm Prax; 1970; 3():62-3. PubMed ID: 5430541
    [No Abstract]   [Full Text] [Related]  

  • 34. Influence of pH on the efficacy of pilocarpine.
    David R; Goldberg L; Luntz MH
    Br J Ophthalmol; 1978 May; 62(5):318-9. PubMed ID: 26375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Extempore prepared ophthalmic solutions and ophthalmic ointments].
    Berggren L; Renström A
    Lakartidningen; 1978 Jan; 75(3):137-40. PubMed ID: 625158
    [No Abstract]   [Full Text] [Related]  

  • 36. [Experiences in filtration of eyedrops over disinfection layers. 1. Method-pilocarpine-eyedrops].
    Greulich J; Keil R
    Pharm Prax; 1968; 3():68-71. PubMed ID: 5731397
    [No Abstract]   [Full Text] [Related]  

  • 37. [Determination of pilocarpine and isopilocarpine by high performance liquid chromatography in normal phase. The stability of eye drops with a pilocarpine base and comparison of this method with a colorimetric method using hydroxylamine].
    Balansard G; Vidal E; Guigues M; Ollivier B; de Meo M
    Pharm Acta Helv; 1986; 61(2):47-50. PubMed ID: 3960937
    [No Abstract]   [Full Text] [Related]  

  • 38. [Methods of stabilizing eyedrops].
    Zelikson IuI
    Farmatsiia; 1975; 24(3):91-4. PubMed ID: 3442
    [No Abstract]   [Full Text] [Related]  

  • 39. A comparative study of the chemical stability of various mitomycin C solutions used in glaucoma filtering surgery.
    Francoeur AM; Assalian A; Lesk MR; Morin I; Tétreault F; Calleja K; Guttman A; Rauth M; Pan SS
    J Glaucoma; 1999 Aug; 8(4):242-6. PubMed ID: 10464732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impending macular hole associated with topical pilocarpine.
    Benedict WL; Shami M
    Am J Ophthalmol; 1992 Dec; 114(6):765-6. PubMed ID: 1463048
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.